192 related articles for article (PubMed ID: 12493542)
21. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
22. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
23. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
24. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.
Rehling M; Frøkiaer J; Poulsen EU; Marqversen J; Nielsen BV; Bacher T
Clin Physiol; 1995 Jan; 15(1):57-71. PubMed ID: 7712693
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
Russell CD; Dubovsky EV
J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
[TBL] [Abstract][Full Text] [Related]
28. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
Shirakawa S; Tamaki N; Torizuka T; Fujita T; Yano S; Tsuchimochi S; Yonekura Y; Konishi J; Terai A
Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
31. 99mTc(CO)3-nitrilotriacetic acid: a new renal radiopharmaceutical showing pharmacokinetic properties in rats comparable to those of 131I-OIH.
Lipowska M; Marzilli LG; Taylor AT
J Nucl Med; 2009 Mar; 50(3):454-60. PubMed ID: 19223406
[TBL] [Abstract][Full Text] [Related]
32. How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.
Bagni B; Bagni I; Orsolon P; Corazzari T
J Nucl Med Technol; 2000 Sep; 28(3):156-8. PubMed ID: 11001496
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate.
Lipowska M; Klenc J; Marzilli LG; Taylor AT
J Nucl Med; 2012 Aug; 53(8):1277-83. PubMed ID: 22717977
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
Fritzberg AR; Kasina S; Eshima D; Johnson DL
J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
[TBL] [Abstract][Full Text] [Related]
36. Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-ortho-iodohippurate and I-125-iothalamate in pigs.
Nielsen SS; Poulsen EU; Marqversen J; Nielsen LE; Bacher T; Rehling M
Clin Physiol; 1999 Jul; 19(4):338-43. PubMed ID: 10451795
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
[TBL] [Abstract][Full Text] [Related]
38. Preliminary Human Radiation Dose Estimates of PET Renal Agents, Para-
Cheki M; Papie M; Mansi L; Kitson S; Gali H
Curr Radiopharm; 2018; 11(1):58-63. PubMed ID: 29437030
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
40. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient.
Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R
Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
